Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Baricitinib improved hair loss and arthritis in a lupus patient.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Finasteride and dutasteride can cause severe, lasting side effects.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Valproic acid microemulsions improve skin delivery compared to regular solutions.

Taking a small dose of the hair growth medicine minoxidil by mouth does not really change your blood pressure.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.